Prostate cancer Board decisions

The Board has decided the case is remanded due to insufficient evidence regarding the Veteran's exposure to herbicide agents during his service in Korea, which could affect his claim for cause of death.

The Board denied service connection for prostate cancer as there was no evidence of herbicide exposure during active duty, and the Veteran's lay assertions were not credible.

The Veteran's prostate cancer residuals are currently rated at 60 percent, and the Board has ordered a remand to assess the current severity of his disability.

The Veteran's claims for service connection for various conditions, including kidney disorder, migraine headaches, depression, and lumbar spine degenerative disc disease (low back pain), have been remanded due to the need for further development.,Service connection has been granted for migraine headaches.

The Veteran's petition to reopen his claims for service connection for diabetes and prostate cancer was granted. Diabetes is now considered service-connected due to presumed exposure to herbicide agents, while prostate cancer is secondary to bladder cancer.

The Veteran's claims for service connection have been remanded due to the need for additional medical examinations and opinions. The issues of entitlement to service connection for coronary artery disease, obstructive sleep apnea, prostate cancer, erectile dysfunction, and a cognitive disability are being reviewed.

The Veteran's claim for service connection for headaches was denied because the evidence did not support a link between his current headaches and active service. His claim for TDIU prior to September 25, 2015 was also denied as he had multiple service-connected disabilities that did not preclude his employability.

The Veteran's appeal for an increased disability rating for prostate cancer is remanded due to the need for a medical opinion evaluating his condition from his last VA examination in 2014 until his passing in 2018.

The Board has remanded the case due to incomplete VA medical records and requests that they be obtained. The Veteran's claim for service connection for prostate cancer, which is presumed due to herbicide exposure, will be reconsidered.

The Veteran's claims for service connection for hypothyroidism, benign prostatic hyperplasia and prostate cancer, diabetes mellitus, and bilateral lower extremity peripheral neuropathy are granted due to presumed exposure to herbicide agents during his active duty service.

The Veteran's prostate cancer is rated at 100% from April 15, 2014 to September 1, 2014 and at 20% thereafter. The Veteran's PTSD is denied an initial rating in excess of 70%. Service connection for hypertension due to herbicide exposure is granted, while service connection for sleep apnea and skin carcinomas are denied.,The Veteran's prostate cancer disability warrants a 100 percent rating from April 15, 2014 to September 1, 2014. From that date onward, the Veteran's prostate cancer disability warrants a 20 percent rating.

The Board denied service connection for prostate cancer, diabetes mellitus type II (DMII), and erectile dysfunction (ED) as claimed due to herbicide exposure. The Veteran's time in Korea was not covered by the legislative presumption of herbicide agent exposure.

The Veteran's service-connected conditions did not render him unable to obtain or maintain substantially gainful employment from April 2, 2015. The Board found that the criteria for a TDIU were not met.

The Veteran's prostate cancer status post prostatectomy is currently rated at 40 percent from September 1, 2014, to December 19, 2019, and at 60 percent thereafter. The Board has ordered remand for further development regarding the active nature of his prostate cancer during the appeal period.

The Veteran's service connection claim for prostate cancer, which was presumed due to exposure at Camp Lejeune, is denied. Service connection for obstructive sleep apnea as secondary to his service-connected depression with anxious distress is granted.

The Board has remanded the Veteran's claims for service connection for prostate cancer, right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy due to exposure to herbicide agents. The AOJ is directed to undertake additional development including verifying the Veteran's reported exposure to herbicide agents in the Korean DMZ.

The Board has granted service connection for the Veteran's prostate cancer and bone cancer, with prostate cancer being granted on a direct basis due to in-service exposure to ionizing radiation. Bone cancer is granted as secondary to the now service-connected prostate cancer.

The Board denied the Veteran's claim for service connection for prostate cancer, including due to herbicide agent exposure, finding no evidence of in-service exposure and insufficient medical evidence linking the condition to his military service.

The Board has granted service connection for prostate cancer and multiple myeloma, finding that the Veteran was exposed to herbicide agents during his service in Korea. These conditions are presumed related due to his exposure.

The Veteran's claim of service connection for prostate cancer was reopened due to new evidence submitted since the last denial. The Board found that while the Veteran served in Southwest Asia during the Gulf War, there is no evidence of herbicide exposure and the prostate cancer is not related to his service.